Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small ...

( NewsNation) — Losing muscle mass isn’t the only potential side effect of taking weight loss medications such as Ozempic: ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

Kids as young as six years old could soon be allowed access to a weight loss drug, similar to Ozempic, to help reduce obesity ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors ...